Indications, Risks, and Management of Lower‑Segment Cesarean Section (LSCS)
Absolute and Relative Indications
- Placenta previa covering the cervical os is an absolute indication for LSCS. 1
- A classic (vertical) uterine scar from a prior cesarean is an absolute contraindication to trial of labor after cesarean (TOLAC). 1
- Fetal macrosomia (estimated weight ≥ 4 kg) is a relative indication for repeat LSCS but does not constitute an absolute contraindication to vaginal birth after cesarean (VBAC). 1
- Maternal comorbidities that require optimization (e.g., anemia, diabetes, hypertension, obesity, cardiac disease) should be addressed before elective LSCS. 2
Pre‑operative Preparation (Elective LSCS)
| Intervention | Evidence Strength | Recommendation |
|---|---|---|
| Chlorhexidine gluconate skin preparation the evening before surgery | Moderate | Weak |
| Administration of a pre‑operative carbohydrate drink | Low‑moderate | Strong |
| Fasting duration tailored to the type and amount of oral intake | Low | Weak |
| Antenatal optimization of anemia, glycemic control, blood pressure, and smoking cessation (10–38 weeks gestation) | — | — |
All items above are supported by the American College of Obstetricians and Gynecologists (ACOG). 2
Long‑Term Risks Associated with Repeated Cesarean Sections
- The incidence of placenta previa rises with each prior cesarean: ~9/1,000 after one, 17/1,000 after two, and 30/1,000 after three or more prior LSCS. 1
- Abnormal placentation (accreta, increta, percreta) risk escalates progressively with each additional cesarean. 1
- The likelihood of requiring hysterectomy increases as the number of previous cesarean deliveries grows. 1
Trial of Labor After Cesarean (TOLAC) – Eligibility and Favorable Factors
- Women with a single prior low‑transverse LSCS may be offered TOLAC after thorough counseling. (Guideline societies: American Family Physician)
- Spontaneous onset of labor is associated with a lower uterine‑rupture risk compared with labor induction. 1
- An inter‑pregnancy interval of ≥ 18 months is a favorable factor for successful TOLAC. 1
- Inter‑pregnancy intervals < 18 months constitute a significant risk factor for uterine rupture during TOLAC. 1
Induction Methods and Uterine‑Rupture Rates in TOLAC
| Induction Method | Reported Rupture Rate (95 % CI) | Recommendation |
|---|---|---|
| Oxytocin infusion | 1.1 % (0.9–1.5 %) | May be used cautiously |
| Misoprostol | 13 % | Absolutely contraindicated |
| Foley catheter | 0 % (no ruptures reported) | Considered safe |
| Prostaglandin E₂ (dinoprostone) | 2 % (1.1–3.5 %) | Should be avoided except in rare circumstances |
Data derived from American Family Physician recommendations. 1
Management of Suspected Uterine Rupture
- When uterine rupture is suspected, an urgent laparotomy should be performed within 18 minutes to optimize maternal and neonatal outcomes. 1
- Neonates delivered ≤ 18 minutes after rupture typically have normal umbilical pH and Apgar scores. 1
- Delivery > 30 minutes after rupture is associated with poorer long‑term neonatal outcomes. 1
Critical Safety Pitfalls (Evidence‑Based Alerts)
- Never use misoprostol in women with a prior cesarean; it carries a 13 % rupture risk. 1
- Never delay laparotomy beyond 18–30 minutes when rupture is suspected. 1
- Never overlook short inter‑pregnancy intervals (< 18 months) during TOLAC counseling, as they heighten rupture risk. 1
Short Interpregnancy Interval After Cesarean Section: Evidence‑Based Recommendations
1. Risk of Uterine Rupture With a < 18‑Month Interval
- An inter‑delivery interval shorter than 18 months is identified as a significant risk factor for uterine rupture, especially during a trial of labor after cesarean (TOLAC). American Academy of Family Physicians guideline recommends heightened surveillance for women with such intervals. 3
2. Counseling on Delivery Mode
Women with an interval of ≤ 6.5 months have a higher baseline risk for complications if they attempt a vaginal birth after cesarean; therefore, a repeat cesarean delivery is generally considered the safer option, though patient preferences must be incorporated. American Academy of Family Physicians advises early, comprehensive counseling about VBAC benefits and harms. 4
If a patient wishes to pursue VBAC despite the short interval, she faces increased risks compared with women who have longer intervals, and the use of misoprostol for cervical preparation or labor induction is absolutely contraindicated. American Academy of Family Physicians emphasizes this contraindication. 5
3. Induction and Misoprostol Contraindications
- Labor induction markedly raises uterine rupture risk in women with a prior cesarean. Reported rupture rates are:
| Induction Agent | Uterine Rupture Rate |
|---|---|
| Oxytocin | 1.1 % |
| Prostaglandin E₂ | 2 % |
| Misoprostol | 13 % |
- Misoprostol is absolutely contraindicated for cervical ripening or labor induction in any woman with a prior cesarean, given the 13 % rupture risk. American Academy of Family Physicians classifies this as a strong contraindication. 7
4. Monitoring for Placental Complications
Prior cesarean delivery increases the incidence of placenta previa to approximately 9 per 1,000 pregnancies; this risk is further amplified when the interpregnancy interval is short. American Academy of Family Physicians recommends targeted ultrasound screening for placenta previa in such patients. 8
The risk of abnormal placentation (accreta spectrum disorders) rises with each successive cesarean. American Academy of Family Physicians advises vigilant antenatal surveillance for these disorders in women with short intervals after cesarean. 3
5. Long‑Term Risks of Repeat Cesarean Delivery
- Each subsequent cesarean delivery incrementally increases the likelihood of abnormal placentation, hysterectomy, and surgical complications in future pregnancies. American Academy of Family Physicians highlights these long‑term maternal morbidities when counseling patients about delivery planning. 7
6. Guideline‑Based Interval Threshold
- The 18‑month interpregnancy interval threshold remains the standard for risk stratification in women with a prior cesarean, as endorsed by American Academy of Family Physicians guidelines. This threshold should guide clinical decision‑making despite isolated studies suggesting otherwise. 4